Evaluation of Physician and Patient Knowledge of Safety and Safe Use Information for Aflibercept

CompletedOBSERVATIONAL
Enrollment

716

Participants

Timeline

Start Date

December 7, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

January 31, 2017

Conditions
Macular Degeneration
Interventions
BEHAVIORAL

Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)

Survey to measure physician awareness and understanding of the key messages in the educational materials: the prescriber guide and video.

BEHAVIORAL

Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)

"Survey to measure patient awareness and understanding of the key messages in the educational materials: the patient booklet Your guide to EYLEA, patient information leaflet, and audio CD."

Trial Locations (5)

Unknown

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

RTI Health Solutions

OTHER

lead

Bayer

INDUSTRY